Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Christopher Kenney
Based on 10 articles published since 2008
||||
Expertise Level
The expertise of Christopher Kenney ranks in the
  • Top 2.7%
  • ... of 69,482 published authors worldwide on Parkinson Disease
  • ... from 2008 through 2019
  • ... based on contributions to 10 articles on the topic.
Graphical view (beta)
Uncounted papers?
Aliases Kenney, Chris   ·   Kenney, C   ·   Kenney, Christopher
Work Locations
Details
Most likely:    Miscellaneous institutions in San Francisco      
2017
  • Department of Clinical Neurosciences, University College London Institute of Neurology, London, United Kingdom. · Department of Medicine, Division of Neurology, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada. · Department of Neurology, University of South Florida College of Medicine, Tampa. · Department of Neurology, Baylor College of Medicine, Houston, Texas. · Parkinson-Klinik, Wolfach, Germany. · Biotie Therapies Inc, San Francisco, California. · Servicio de Neurología, Sant Pau Hospital, Universidad Autonoma de Barcelona, Universitat Oberta de Catalunya, Barcelona, Spain. · Department of Neurology, University of Kansas Medical Center, Kansas City. · Department of Neurology, Medical University Innsbruck, Innsbruck, Austria. · APC, St Moritz, Switzerland. · Pubmed 27942720
2014
  • University of South Florida Parkinson's Disease and Movement Disorders Center, National Parkinson Foundation Center of Excellence, Tampa, FL, USA. Electronic address: · Department of Neurology, Mount Sinai School of Medicine, New York, NY, USA. · University of Rochester School of Medicine, Rochester, NY, USA. · Clinique Sainte-Anne Mémoire et Mouvement, Faculty of Medicine, Laval University, Quebec, QC, Canada. · Department of General Medicine, Ovidius University of Constanta, Constanta, Romania. · Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. · Department of General Neurology, Zaporizhzhya State Medical University, Zaporizhzhya, Ukraine. · Biotie Therapies, South San Francisco, CA, USA. · Pubmed 25008546
Probable:    Novartis      
2016
  • Paracelsus-Elena Klinik, Kassel 34128, Germany; Department of Neurosurgery, University Medical Center, Goettingen, Germany. · IRCCS San Raffaele Pisana, Rome, Italy. · Department of Neurology, Medical University, Innsbruck, Austria. · Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA. · Novartis Pharma AG, Basel, Switzerland. · Pubmed 27214258
  • a 1 Rocky Mountain Movement Disorders Center, Colorado Neurological Institute , Englewood , CO , USA. · b 2 USF Health Byrd Institute , Tampa , FL , USA. · c 3 Novartis Pharmaceuticals Corporation , East Hanover , NJ , USA. · d 4 Novartis Pharma AG , Basel , Switzerland. · Pubmed 24007304
2014
  • Clinical Investigation Center CIC9302 and Department of Neurosciences and Clinical Pharmacology, INSERM UMR825, Toulouse University Hospital and University of Toulouse III, Toulouse, France. · Movement Disorder Clinic, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada. · Novartis Institutes for Biomedical Research, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Neuroscience Research Unit, Centre Hospitalier Universitaire de Québec, Québec, Canada; Faculty of Pharmacy, Laval University, Québec, Canada. · Novartis Institutes for Biomedical Research, Basel, Switzerland; Department of Neurology and Neurosurgery, McGill University, Montreal, Québec, Canada. Electronic address: · Pubmed 24951359
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Christopher Kenney in 2008-2019 about Parkinson Disease:

  • Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial. 2017
  • Mavoglurant in Parkinson's patients with l-Dopa-induced dyskinesias: Two randomized phase 2 studies. 2016
  • Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients. 2016
  • Assessment of Parkinson's disease levodopa-induced dyskinesia: a qualitative research study. 2015
  • Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias. 2014
  • Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial. 2014
  • AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study. 2013
  • Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease. 2012
  • CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. 2008
  • Bilateral pedunculopontine nuclei strokes presenting as freezing of gait. 2008
Show List of Full Article Records
Google Searches

Learn more about Christopher Kenney using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in San Francisco
Novartis
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in San Francisco
2017
  • Department of Clinical Neurosciences, University College London Institute of Neurology, London, United Kingdom. · Department of Medicine, Division of Neurology, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada. · Department of Neurology, University of South Florida College of Medicine, Tampa. · Department of Neurology, Baylor College of Medicine, Houston, Texas. · Parkinson-Klinik, Wolfach, Germany. · Biotie Therapies Inc, San Francisco, California. · Servicio de Neurología, Sant Pau Hospital, Universidad Autonoma de Barcelona, Universitat Oberta de Catalunya, Barcelona, Spain. · Department of Neurology, University of Kansas Medical Center, Kansas City. · Department of Neurology, Medical University Innsbruck, Innsbruck, Austria. · APC, St Moritz, Switzerland. · Pubmed 27942720
2014
  • University of South Florida Parkinson's Disease and Movement Disorders Center, National Parkinson Foundation Center of Excellence, Tampa, FL, USA. Electronic address: · Department of Neurology, Mount Sinai School of Medicine, New York, NY, USA. · University of Rochester School of Medicine, Rochester, NY, USA. · Clinique Sainte-Anne Mémoire et Mouvement, Faculty of Medicine, Laval University, Quebec, QC, Canada. · Department of General Medicine, Ovidius University of Constanta, Constanta, Romania. · Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. · Department of General Neurology, Zaporizhzhya State Medical University, Zaporizhzhya, Ukraine. · Biotie Therapies, South San Francisco, CA, USA. · Pubmed 25008546
Novartis
2016
  • Paracelsus-Elena Klinik, Kassel 34128, Germany; Department of Neurosurgery, University Medical Center, Goettingen, Germany. · IRCCS San Raffaele Pisana, Rome, Italy. · Department of Neurology, Medical University, Innsbruck, Austria. · Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA. · Novartis Pharma AG, Basel, Switzerland. · Pubmed 27214258
  • a 1 Rocky Mountain Movement Disorders Center, Colorado Neurological Institute , Englewood , CO , USA. · b 2 USF Health Byrd Institute , Tampa , FL , USA. · c 3 Novartis Pharmaceuticals Corporation , East Hanover , NJ , USA. · d 4 Novartis Pharma AG , Basel , Switzerland. · Pubmed 24007304
2014
  • Clinical Investigation Center CIC9302 and Department of Neurosciences and Clinical Pharmacology, INSERM UMR825, Toulouse University Hospital and University of Toulouse III, Toulouse, France. · Movement Disorder Clinic, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada. · Novartis Institutes for Biomedical Research, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Neuroscience Research Unit, Centre Hospitalier Universitaire de Québec, Québec, Canada; Faculty of Pharmacy, Laval University, Québec, Canada. · Novartis Institutes for Biomedical Research, Basel, Switzerland; Department of Neurology and Neurosurgery, McGill University, Montreal, Québec, Canada. Electronic address: · Pubmed 24951359
5 Other Locations Show
Yearly article counts 001212110002
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.